Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,405.20
(
-2.38%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
0.00%
)
Bitcoin
66,591.25
(
0.41%
)
News Focus
News Focus
Post# of 257302
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122817
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 217787

Friday, 03/16/2018 10:34:03 AM

Friday, March 16, 2018 10:34:03 AM

Post# of 257302
Mavyret’s US market share continues growth—week ending 3/9/18 (according to IMS):

• ABBV/ENTA’s NRx share=43.1%, the highest-ever weekly figure, blowing past the previous high of 39.6% in the preceding week.

• ABBV/ENTA’s TRx share=38.2%, also the highest-ever weekly figure, up from the previous high of 35.1% in the preceeding week.

(Almost all of ABBV/ENTA’s US HCV business now comes from Mavyret.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up